CRESCENT BIOPHARMA, INC. - CBIO

All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)? Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).

Files summary

Total files loaded: 24
Latest filed: Jul 20, 2026
Form Count
4 13
8-K 5
SCHEDULE 13G/A 3
SCHEDULE 13G 2
SCHEDULE 13D/A 1

Latest files

Filed Form Report period Accession SEC
Jul 20, 2026 4 Jul 16, 2026 0001104659-26-085113 View
Jul 20, 2026 SCHEDULE 13D/A 0001104659-26-085114 View
Jul 15, 2026 8-K Jul 14, 2026 0001628280-26-048347 View
Jul 14, 2026 8-K Jul 14, 2026 0001628280-26-048151 View
Jun 23, 2026 4 Jun 22, 2026 0001628280-26-044893 View
Jun 23, 2026 4 Jun 22, 2026 0001628280-26-044884 View
Jun 23, 2026 4 Jun 22, 2026 0001628280-26-044885 View
Jun 23, 2026 4 Jun 22, 2026 0001628280-26-044886 View
Jun 23, 2026 4 Jun 22, 2026 0001628280-26-044887 View
Jun 23, 2026 4 Jun 22, 2026 0001628280-26-044890 View
Jun 23, 2026 4 Jun 22, 2026 0001628280-26-044892 View
Jun 03, 2026 4 Jun 02, 2026 0001628280-26-040575 View
Jun 03, 2026 4 Jun 02, 2026 0001628280-26-040577 View
Jun 03, 2026 4 Jun 02, 2026 0001628280-26-040580 View
Jun 03, 2026 4 Jun 02, 2026 0001628280-26-040582 View
Jun 03, 2026 4 Jun 02, 2026 0001628280-26-040583 View
Jun 03, 2026 8-K Jun 02, 2026 0001628280-26-040051 View
May 15, 2026 SCHEDULE 13G/A 0001214659-26-006496 View
May 15, 2026 SCHEDULE 13G 0001193125-26-225181 View
Apr 29, 2026 8-K Apr 29, 2026 0001628280-26-028386 View
Feb 26, 2026 8-K Feb 26, 2026 0001628280-26-011988 View
Feb 17, 2026 SCHEDULE 13G 0000902664-26-001077 View
Feb 17, 2026 SCHEDULE 13G/A 0001738048-26-000018 View
Feb 05, 2026 SCHEDULE 13G/A 0000315066-26-000413 View